Position in KRYS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$63,016,647
+$21,150,725 QoQ
Shares Held
169,550
+4.6% QoQ
Ownership
0.573%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#28
of 419 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. KRYS ranks #9 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in KRYS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,016,647 | 169,550 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $41,865,922 | 162,070 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $40,697,343 | 165,074 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $25,216,074 | 142,843 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $19,365,776 | 140,883 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $22,778,561 | 126,337 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $19,340,146 | 123,453 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $21,793,723 | 119,726 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $22,673,846 | 123,469 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $1,060,284 | 5,959 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $719,423 | 5,799 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $669,088 | 5,768 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $691,837 | 5,893 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $491,007 | 6,133 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $447,830 | 5,653 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $375,612 | 5,389 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $304,661 | 4,640 | Shares | Defined | 2022-08-10 | |
| 2021-09-30 | $227,426 | 4,356 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $344,080 | 5,060 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $584,193 | 7,583 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $454,200 | 7,570 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||